| Description |
1 online resource |
| Contents |
Front Cover; Risk Management in Transfusion Medicine; Risk Management in Transfusion Medicine; Copyright; Dedication; List of Contributors; Preface; Contents; 1 -- Enterprise Risk Management-What It Is and Why It Matters; INTRODUCTION; SARBANES-OXLEY ACT OF 2002; PERFORMING A RISK AUDIT; RISK RESPONSE; REFERENCES; 2 -- Quality Systems in Transfusion Medicine; THE RELATIONSHIP BETWEEN RISK AND QUALITY; FAILURE MODE AND EFFECTS ANALYSIS; ROOT CAUSE ANALYSIS; LEAN AND SIX SIGMA; QUALITY SYSTEM ESSENTIALS; REFERENCES; 3 -- Regulatory Oversight of Transfusion Medicine; FDA REGULATION |
|
THE CLINICAL LABORATORY IMPROVEMENT ACT OF 1967 AND THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988 (CLIA '88)OTHER REGULATIONS THAT IMPACT TRANSFUSION RISK MANAGEMENT; REFERENCES; 4 -- Procedures for Protection; INTRODUCTION; UNDERSTANDING THE STANDARDS; QSE 1: Organization; QSE 2: resources (human resources); QSE 3: equipment; QSE 4: supply and customer issues; QSE 5: process control; QSE 6: documents and records; QSE 7: deviations, nonconformances, and adverse events; QSE 8: assessments-internal and external; QSE 9: process improvement through corrective and preventative action |
|
QSE 10: facilities and safetyREFERENCES; 5 -- Transfusion-Transmitted Infectious Diseases; DONOR SCREENING; INFECTIOUS DISEASES TESTING; Mandatory Infectious Diseases Testing; Hepatitis B Virus; Hepatitis C virus; Human Immunodeficiency virus; Human T-Lymphotropic virus; West Nile virus; Zika virus; Chagas; Babesia-A Potential Candidate for Mandatory Donor Testing?; Transmissible Spongiform Encephalopathies; Malaria Deferrals; NATIONAL DONOR DEFERRAL REGISTRIES; QUARANTINE; PROBLEMS AND DEFICIENCIES; REMARKS; REFERENCES; 6 -- Transfusion Review: Monitoring Transfusion Practice |
|
How Much Blood Is Transfused?WHO IS BEING TRANSFUSED?; WHY IS BLOOD TRANSFUSED?; EARLY STEPS TO IMPROVE PHYSICIAN PRESCRIBING PRACTICES; AUDITING AND MONITORING PHYSICIAN PRESCRIBING PRACTICES; Providing Physician Feedback; CONCLUSION; Appendix: Red Cell Transfusion inNormovolemic Anemia; RED CELL TRANSFUSION IN NORMOVOLEMIC INPATIENTS; WHAT IS NORMOVOLEMIC ANEMIA?; I'VE SEEN OTHER PHYSICIANS ORDER 2 UNITS OF RED CELLS FOR THESE PATIENTS. WHAT WRONG WITH THIS?; WHY SHOULD I WAIT 4-6H?; WHAT ABOUT OUTPATIENTS?; WHAT ARE THE DATA? |
|
THIS DOESN'T MAKE SENSE. IF I TRANSFUSE A PATIENT WHO HAS A HEMOGLOBIN LESS THAN 10G/DL, I MUST BE DOING SOME GOOD SINCE OXYGEN ... ARE THERE PATIENTS WHOM I SHOULD TRANSFUSE PROPHYLACTICALLY?; IS THIS APPROACH SUPPORTED BY EXPERT OPINION?; REFERENCES; 7 -- Patient Blood Management: Reducing Risk by Reducing Inappropriate and Avoidable Transfusions; INTRODUCTION; Unnecessary Red Blood Cell Transfusions; Inappropriate red blood cell transfusions; Avoidable red blood cell transfusion; Unnecessary Plasma Transfusion; Inappropriate plasma transfusion; Avoidable plasma transfusion |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Unnecessary Platelet Transfusion |
|
Print version record |
| Subject |
Blood -- Transfusion.
|
|
Blood -- Transfusion -- Safety measures
|
|
Blood Transfusion
|
|
Blood -- Transfusion
|
|
Blood -- Transfusion -- Safety measures
|
| Form |
Electronic book
|
| ISBN |
0323548385 |
|
9780323548380 |
|
